TITLEIST CAPITAL, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.

Quarter-by-quarter ownership
TITLEIST CAPITAL, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2022$2,198,595
+262.2%
76,713
+205.0%
0.52%
+270.5%
Q3 2022$607,000
+75.4%
25,148
+99.0%
0.14%
+65.5%
Q2 2022$346,000
-28.7%
12,6400.0%0.08%
-12.5%
Q1 2022$485,000
-0.4%
12,640
-16.9%
0.10%
+2.1%
Q4 2021$487,00015,2020.09%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders